Lucentis and Carafate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lucentis (ranibizumab) and Carafate (sucralfate). Common drug interactions include blindness among females and drug hypersensitivity among males.

The phase IV clinical study analyzes what interactions people have when they take Lucentis and Carafate. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Carafate?

Carafate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 14,028 Carafate users. Check the latest studies of Carafate.

On Jul, 12, 2026

12 people who take Lucentis and Carafate together, and have interactions are studied.

Lucentis and Carafate drug interactions.

What are the common drug interactions of Lucentis and Carafate, by gender? *:

female:

Blindness
Lung infection
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pneumonia
Renal failure chronic (long lasting kidney dysfunction)
Abdominal pain
Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
Ascites (accumulation of fluid in the abdominal cavity)
Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

male:

Drug hypersensitivity

What are the common drug interactions of Lucentis and Carafate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Blindness
Corneal degeneration (abnormal deposition of substances in the transparent front part of the eye)
Lung infection
Pneumonia
Abdominal pain
Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
Ascites (accumulation of fluid in the abdominal cavity)
Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood creatinine increased

What are the existing conditions these people have? *

Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 3 people, 25.00%
Age-Related Macular Degeneration: 3 people, 25.00%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 16.67%
Pain: 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 16.67%
Hyperchlorhydria (gastric acid levels are higher in stomach): 2 people, 16.67%
Gastric Ulcer (stomach ulcer): 2 people, 16.67%
Dizziness: 2 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and Carafate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously